7/9/2026

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Dulcivit Novum

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
1 1
1 1

Multivitaminer

Multivitaminer

Klass : 1

Visa all info

Skriv ut

Kontakta oss

  1. Lumley J, Watson L, Watson M, Bower C. Modelling the potential impact of population-wide perconceptional folate/multivitamin supplementation on multiple births. BJOG 2001;108:937-42.

  2. Ericson A, Källén B, Åberg A. Use of multivitamins and folic acid in early pregnancy and multiple births in Sweden. Twin Res 2001;4:63-6.

  3. Berry RJ, Li Z, Erickson JD et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485-90.

  4. Rosano A, Smithells D, Cacciani L et al. Time trends in neural tube defects prevalence in relation to preventive strategies: an international study. J Epidemiol Community Health 1999;53:630-5.

  5. Botto LD, Mulinare J, Erickson JD. Occurrence of congenital heart defects in relation to maternal mulitivitamin use. Am J Epidemiol 2000;151:878-84.

  6. Mulinare J, Cordero JF, Erickson JD et al. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260:3141-5.

  7. Milunsky A, Jick H, Jick SS et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-52.

  8. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.

  9. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-61.

  10. Czeizel AE, Metneki J, Dudas I. Higher rate of multiple births after periconceptional vitamin supplementation. N Engl J Med 1994;330:1687-8.

  11. Shaw GM, Schaffer D, Velie EM et al. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6:219-26.

  12. Botto LD, Khoury MJ, Mulinare J et al. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 1996;98:911-7.

  13. Werler MM, Cragan JD, Wasserman CR et al. Multivitamin supplementation and multiple births. Am J Med Genet 1997;71:93-6.

  14. Scanlon KS, Ferencz C, Loffredo CA et al. Preconceptional folate intake and malformations of the cardiac outflow tract. Baltimore-Washington Infant Study Group. Epidemiology 1998;9:95-8.

  15. Hall J, Solehdin F. Folic acid for the prevention of congenital anomalies. Eur J Pediatr 1998;157:445-50.

  16. Kadir RA, Sabin C, Whitlow B et al. Neural tube defects and periconceptional folic acid in England and Wales: retrospective study. BMJ 1999;319:92-3.

  1. Lumley J, Watson L, Watson M, Bower C. Modelling the potential impact of population-wide perconceptional folate/multivitamin supplementation on multiple births. BJOG 2001;108:937-42.
  2. Ericson A, Källén B, Åberg A. Use of multivitamins and folic acid in early pregnancy and multiple births in Sweden. Twin Res 2001;4:63-6.
  3. Berry RJ, Li Z, Erickson JD et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485-90.
  4. Rosano A, Smithells D, Cacciani L et al. Time trends in neural tube defects prevalence in relation to preventive strategies: an international study. J Epidemiol Community Health 1999;53:630-5.
  5. Botto LD, Mulinare J, Erickson JD. Occurrence of congenital heart defects in relation to maternal mulitivitamin use. Am J Epidemiol 2000;151:878-84.
  6. Mulinare J, Cordero JF, Erickson JD et al. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260:3141-5.
  7. Milunsky A, Jick H, Jick SS et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-52.
  8. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
  9. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-61.
  10. Czeizel AE, Metneki J, Dudas I. Higher rate of multiple births after periconceptional vitamin supplementation. N Engl J Med 1994;330:1687-8.
  11. Shaw GM, Schaffer D, Velie EM et al. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6:219-26.
  12. Botto LD, Khoury MJ, Mulinare J et al. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 1996;98:911-7.
  13. Werler MM, Cragan JD, Wasserman CR et al. Multivitamin supplementation and multiple births. Am J Med Genet 1997;71:93-6.
  14. Scanlon KS, Ferencz C, Loffredo CA et al. Preconceptional folate intake and malformations of the cardiac outflow tract. Baltimore-Washington Infant Study Group. Epidemiology 1998;9:95-8.
  15. Hall J, Solehdin F. Folic acid for the prevention of congenital anomalies. Eur J Pediatr 1998;157:445-50.
  16. Kadir RA, Sabin C, Whitlow B et al. Neural tube defects and periconceptional folic acid in England and Wales: retrospective study. BMJ 1999;319:92-3.
2 2
2 2

Kolekalciferol

Kolekalciferol

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Moon RJ, Harvey NC, Cooper C. ENDOCRINOLOGY IN PREGNANCY: Influence of maternal vitamin D status on obstetric outcomes and the fetal skeleton . Eur J Endocrinol. 2015 Aug,173(2):R69-83.

  2. UK Teratology Information Service (UKTIS). USE OF VITAMIN D IN PREGNANCY March 2026. UKTIS [www]. [cited 2026-07-03].

  3. Palacios C, Kostiuk LL, Cuthbert A, Weeks J . Vitamin D supplementation for women during pregnancy . Cochrane Database Syst Rev. 2024 Jul 30;7(7):CD008873.

  4. Jutell M, Bhat S, Bagge ML, Isberg PE, Wiberg N. Correlation between maternal and umbilical cord 25-hydroxy-vitamin D levels over a range of values A prospective observational study from the United Arab Emirates. PLoS One. 2024 Apr 23;19(4):e0299862.

  5. Briggs G, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 12th ed; 2021.

  6. D-vitamin under graviditet och amning En litteraturstudie om status, intag och samband med hälsa. Livsmedelsverket ISSN 1104-7089 [www]. [cited 2026-07-03].

  7. D-vitamintillskott under graviditet . Kunskapsstöd för vårdgivare [www]. [updated 2026-06-01, cited 2026-07-03].

  8. Reynolds A, O'Connell SM, Kenny LC, Dempsey E . Transient neonatal hypercalcaemia secondary to excess maternal vitamin D intake: too much of a good thing. BMJ Case Rep. 2017 Jul 6;2017:bcr2016219043

  9. Karacan Küçükali G, Keskin M, Savaş Erdeve Ş, Çetinkaya S. Perinatal outcomes of high-dose vitamin D administration in the last trimester. Turk J Obstet Gynecol. 2021;18(2):159-162.

  10. Reprotox. Vitamin D. Micromedex [www]. [cited 2026-07-03].

  11. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL . Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner ResJ Bone Miner Res. 2011;26(10):2341-57.

  12. Marx SJ, Swart EG Jr, Hamstra AJ, DeLuca HF. Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1980;51(5):1138-42.

  1. Moon RJ, Harvey NC, Cooper C. ENDOCRINOLOGY IN PREGNANCY: Influence of maternal vitamin D status on obstetric outcomes and the fetal skeleton . Eur J Endocrinol. 2015 Aug,173(2):R69-83.
  2. UK Teratology Information Service (UKTIS). USE OF VITAMIN D IN PREGNANCY March 2026. UKTIS [www]. [cited 2026-07-03].
  3. Palacios C, Kostiuk LL, Cuthbert A, Weeks J . Vitamin D supplementation for women during pregnancy . Cochrane Database Syst Rev. 2024 Jul 30;7(7):CD008873.
  4. Jutell M, Bhat S, Bagge ML, Isberg PE, Wiberg N. Correlation between maternal and umbilical cord 25-hydroxy-vitamin D levels over a range of values A prospective observational study from the United Arab Emirates. PLoS One. 2024 Apr 23;19(4):e0299862.
  5. Briggs G, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 12th ed; 2021.
  6. D-vitamin under graviditet och amning En litteraturstudie om status, intag och samband med hälsa. Livsmedelsverket ISSN 1104-7089 [www]. [cited 2026-07-03].
  7. D-vitamintillskott under graviditet . Kunskapsstöd för vårdgivare [www]. [updated 2026-06-01, cited 2026-07-03].
  8. Reynolds A, O'Connell SM, Kenny LC, Dempsey E . Transient neonatal hypercalcaemia secondary to excess maternal vitamin D intake: too much of a good thing. BMJ Case Rep. 2017 Jul 6;2017:bcr2016219043
  9. Karacan Küçükali G, Keskin M, Savaş Erdeve Ş, Çetinkaya S. Perinatal outcomes of high-dose vitamin D administration in the last trimester. Turk J Obstet Gynecol. 2021;18(2):159-162.
  10. Reprotox. Vitamin D. Micromedex [www]. [cited 2026-07-03].
  11. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL . Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner ResJ Bone Miner Res. 2011;26(10):2341-57.
  12. Marx SJ, Swart EG Jr, Hamstra AJ, DeLuca HF. Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1980;51(5):1138-42.